Core Viewpoint - The stock price of Giant Bio (02367) has dropped over 3%, reaching a new low of 35.54 HKD, reflecting a significant decline since May due to controversies surrounding collagen protein components [1] Company Summary - The stock price has halved since its peak in May, currently trading at 35.68 HKD with a trading volume of 199 million HKD [1] - The brand's product, Kefu Mei, has fallen out of the top 10 in the Douyin beauty rankings for this year's Double Eleven, and ranked 18th in the Tmall beauty rankings, a drop of 5 places from last year [1] - Kefu Mei has consistently dropped out of the top 20 in Douyin beauty rankings since June [1] Industry Summary - Domestic brands secured 5 out of the top 10 spots in the Douyin beauty rankings for this year's Double Eleven, indicating increased competition in the collagen protein market [1] - Jianghai Securities suggests monitoring Giant Bio's future marketing strategies and sales performance in response to the growing number of players in the collagen protein industry [1]
港股异动 | 巨子生物(02367)跌超3%刷新年内新低 股价较5月高点已腰斩 可复美双十一排名下滑